Monday, August 24, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
RegulatoryAbbVie Launches Phase 2 Forehead Lines StudytodayMarketFacial Rejuvenation Market Forecast to Hit $5.66B by 20302 days agoBusiness & M&AAllergan Aesthetics Overhauls Loyalty ProgramtodayDevices & TechXERF Technology Enters Australian Market for Skin Tightening2 days agoBusiness & M&AEvolus Expands Estyme to Canada, Australia, New ZealandtodayMarketArm Fat Now Top Body Sculpting Concern in Singapore2 days agoDevices & TechSofwave Hits One Million Treatments MilestonetodayRegulatoryCKD Bio Pursues China Botox Approval—2027 Launch Targeted2 days agoRegulatoryRevance Wins FDA Nod for Under-Eye InjectablesyesterdayMarketGLP-1 Pill Era Is Forcing Beauty Market ShiftyesterdayInjectablesAEON Releases Expanded ABP-450 Botox Biosimilar DatayesterdayDevices & TechUltherapy PRIME Real-Time Imaging Reshapes Midface Liftingyesterday
Fed & Macro

Quantitative Easing

The Fed buying bonds to inject liquidity and push down long rates, a tailwind for risk assets.

Also known as: QE, Asset Purchases

What it is
Quantitative easing is the Fed's purchase of Treasuries and mortgage-backed securities to expand its balance sheet and lower long-term rates. It adds liquidity when short-term rates are already near zero. It is the opposite of quantitative tightening.
What it does
QE lowers discount rates and floods markets with liquidity, historically supporting equities, credit, and long-duration growth assets. The mere signal of resumed purchases can lift risk appetite. Investors position for the liquidity regime it creates.
The evidence
Rounds of QE coincided with multi-year rallies in equities and compression in credit spreads and long yields.
Best for
Long-duration growth (XLK, QQQ), credit and bond proxies (LQD, TLT).
Pairs well with
quantitative-tightening, fomc, federal-funds-rate
Use cautiously with
Correlation is not mechanism; crediting every rally to QE ignores earnings and other drivers.
Cautions
QE is typically a crisis tool, so its arrival often accompanies bad news that first roils markets.
General information, not medical advice. Ingredient effects vary by formulation, concentration, and skin. Patch-test new actives and consult a qualified provider before starting prescription ingredients.

More fed & macro

Know what's coming before your patients ask for it.

New actives, device launches, and the FDA calls that change what you can offer — distilled into a two-minute brief, twice a week. Inside MedSpa Pro.

Go Pro · $20/mo
Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
The twice-a-week intelligence brief Go Pro · $20/mo →